Text Size

Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer

This study has been terminated.
Sponsor:
Collaborator:
Varian Medical Systems
Information provided by (Responsible Party):
Quynh-Thu Le, Stanford University
ClinicalTrials.gov Identifier:
NCT01011842
First received: November 9, 2009
Last updated: April 6, 2012
Last verified: April 2012
History of Changes
  Purpose

To determine if a new optical system that can track a patient's movement during treatment can be used to measure motion and allow for motion adjustments in order to decrease the amount of healthy tissue that receives radiation without limiting our ability to cure cancers using radiation.


Condition Intervention
Head and Neck Cancer
 Procedure: Radiotherapy
Procedure: Align RT

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Comparison of Intrafraction Motion in Patients With Head and Neck Cancer Using Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • We are measuring how much a patient moves during treatment. [ Time Frame: This information will be available immediately have the patient is treated. ] [ Designated as safety issue: No ]

Enrollment: 11
Study Start Date: October 2009
Study Completion Date: November 2011
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Radiotherapy
    Standard of care
    Other Names:
    • Radiation therapy
    • radiation oncology
    Procedure: Align RT
    Standard of care
    Other Name: Image-Guided Radiation Therapy
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with HNC undergoing radiation therapy at Stanford University
  • Age >= 18 years old
  • Radiation course >= 4 weeks duration
  • Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

  • Factors such as claustrophobia inhibiting use of thermoplastic mask immobilization device.
  • Patients who are pregnant or nursing, which preclude them from undergoing active radiation treatment.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01011842

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Varian Medical Systems
Investigators
Principal Investigator: Quynh-Thu Le Stanford University
  More Information

No publications provided

Responsible Party: Quynh-Thu Le, Professor, Stanford University
ClinicalTrials.gov Identifier: NCT01011842     History of Changes
Other Study ID Numbers: ENT0028, SU-09082009-3800
Study First Received: November 9, 2009
Last Updated: April 6, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms

ClinicalTrials.gov processed this record on May 19, 2013